Neil Nardini, PA
Physician Assistant · Palmer, AKNPI 1871879718
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 202 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 23.6% — the pattern of someone who eats at a lot of different presentations. Among physician assistant clinicians in AK with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 202 payments — averaging $24.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- AbbVie$960
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$424
- Amgen$256
- Novo Nordisk$255
- Lilly USA, LLC$200
- plus $2K from 27 others
What the payments were for
- Food & beverage$4,848100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 42 | $1,143 |
| AbbVie | 40 | $960 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 16 | $424 |
| Amgen | 6 | $256 |
| Novo Nordisk | 13 | $255 |
| Lilly USA, LLC | 9 | $200 |
| Pfizer | 10 | $196 |
| GSK | 8 | $179 |
| Novartis | 7 | $151 |
| Exact Sciences | 4 | $109 |
| Merck | 5 | $85 |
| Astellas Pharma US Inc | 4 | $84 |
| Biohaven Pharmaceuticals, Inc. | 4 | $82 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $80 |
| Sumitomo Pharma America, Inc. | 3 | $69 |
| Johnson & Johnson | 4 | $64 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $62 |
| Amarin Pharma, Inc. | 3 | $55 |
| Boehringer Ingelheim | 2 | $43 |
| E.r. Squibb & Sons, L.L.C. | 2 | $41 |
| Digestive Care, Inc. | 1 | $31 |
| Idorsia Pharmaceuticals US Inc | 1 | $30 |
| Nestle Healthcare Nutrition Inc. | 1 | $28 |
| Echosens North America, Inc. | 1 | $26 |
| Tactile Systems Technology Inc | 1 | $24 |
| Nevro Corp. | 1 | $23 |
| Medtronic | 1 | $23 |
| Bayer | 1 | $23 |
| Alkermes, Inc. | 1 | $22 |
| Acadia Pharmaceuticals Inc | 1 | $21 |
| Teva Pharmaceuticals USA, Inc. | 1 | $21 |
| Eisai Inc. | 1 | $19 |
| Philips North America LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,848 in reported general payments places this provider in the 95th percentile of 365 physician assistant providers in Alaska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 30 | $39,775 |
| TrulicityDulaglutide | 22 | $31,042 |
| XareltoRivaroxaban | 26 | $25,216 |
| JardianceEmpagliflozin | 18 | $21,123 |
| OzempicSemaglutide | 14 | $17,976 |
| FarxigaDapagliflozin Propanediol | 21 | $16,570 |
| Celecoxib | 37 | $1,068 |
| SynthroidLevothyroxine Sodium | 15 | $1,048 |
| Omeprazole | 56 | $938 |
| Tamsulosin Hcl | 46 | $767 |
| Atorvastatin Calcium | 55 | $674 |
| Amlodipine Besylate | 74 | $657 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 14 | $631 |
| Valsartan | 16 | $616 |
| FenofibrateFenofibrate Nanocrystallized | 14 | $551 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta | $179 | $39,77530 claims |
| Lilly USA, LLCTrulicity | $200 | $31,04222 claims |
| Johnson & JohnsonXarelto | $64 | $25,21626 claims |
| Boehringer IngelheimJardiance | $43 | $21,12318 claims |
| Novo NordiskOzempic | $255 | $17,97614 claims |
| AstraZenecaFarxiga | $1,143 | $16,57021 claims |
| AbbVieSynthroid | $960 | $1,04815 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 365 physician assistant providers in Alaska.
Other physician assistant in Palmer
- Jordan StancombePalmer$5K
- Mary EckartPalmer$1K
- Jeremy RosieckiAnchorage$93K
- Ivy ParayoAnchorage$12K
- Shannon DieffenderferAnchorage$11K
- Zach ZipsirAnchorage$8K
- James LafleurFairbanks$8K
- Tara WoodAnchorage$8K
- Jared WallaceKenai$7K
- Madison RosinAnchorage$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.